Internal Medicine, Endocrinology, Diabetes, & Metabolism · Clearwater, FL
NPI
1174867378
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
430 Pinellas St Ste 400
Clearwater, FL, 33756
Phone (727) 461-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
1,846 services
Medicare patients, 2024
302
Average age 75
Drug cost, 2024
$1.9M
3,724 prescriptions
Company payments, 2025
$2,740
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wenge Lu was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 496 times for 256 patients. In total Wenge Lu billed 1,846 services in 16 codes, and Medicare paid $94K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 496 | 256 | $12.48 | $6,190 |
| 99215 Office E&M - Established | Office | 364 | 171 | $129.93 | $47K |
| 99214 Office E&M - Established | Office | 251 | 141 | $88.97 | $22K |
| 83036 Blood Count | Office | 245 | 147 | $9.41 | $2,305 |
| 95251 Test - Miscellaneous | Office | 220 | 92 | $25.05 | $5,510 |
| 82947 Clinical Chemistry | Office | 134 | 88 | $3.85 | $516 |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 16 | $61.37 | $3,191 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $129.74 | $2,076 |
By year: 2022 $104K for 1,721 services; 2023 $99K for 1,614 services; 2024 $94K for 1,846 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 245 | 147 | $9.41 | $2,305 |
| 82947 Clinical Chemistry | 134 | 88 | $3.85 | $516 |
Medicare prescription drug claims, 2024
In 2024, the drug Wenge Lu prescribed most often to Medicare patients was Levothyroxine Sodium, with 435 prescriptions and refills. In total Wenge Lu wrote 3,724 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 435 | 1,235 | 112 | $5,059 |
| Ozempic Semaglutide | 303 | 488 | 67 | $449K |
| Metformin Hcl Generic | 184 | 519 | 58 | $1,708 |
| Jardiance Empagliflozin | 179 | 444 | 54 | $249K |
| Synthroid Levothyroxine Sodium | 111 | 286 | 24 | $12K |
| Mounjaro Tirzepatide | 109 | 143 | 24 | $151K |
| Metformin Hcl Er Metformin Hcl | 98 | 264 | 37 | $1,228 |
| Glimepiride Generic | 96 | 267 | 32 | $1,277 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 81 | 190 | 30 | $14K |
| Liothyronine Sodium Generic | 79 | 238 | 27 | $3,204 |
| Pioglitazone Hcl Generic | 69 | 153 | 20 | $1,351 |
| Januvia Sitagliptin Phosphate | 68 | 141 | 16 | $77K |
| Gabapentin Generic | 65 | 180 | 27 | $1,600 |
| Tresiba Flextouch U-200 Insulin Degludec | 64 | 140 | 25 | $72K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 64 | 116 | 11 | $72K |
Brand drugs: 2,071 claims; generic drugs: 1,373 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wenge Lu $2,740 ($2,740 in general payments such as food, travel and fees) from 31 companies. The largest payer was Novo Nordisk Inc with $424.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 24 | $424 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $245 |
| Abbott Laboratories ABT | 12 | $233 |
| Sanofi-Aventis U.S. LLC SNY | 6 | $178 |
| Corcept Therapeutics CORT | 8 | $148 |
| Dexcom, Inc. DXCM | 5 | $121 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $112 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $103 |
| Amgen Inc. AMGN | 6 | $98.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.